Inventor
KORNELUK ROBERT G
CA30 patents
⚠️ This page may combine multiple inventors who share the name “KORNELUK ROBERT G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV OTTAWA
12 patentsUS6156535ADec 5, 2000
Mammalian IAP gene family, primers, probes, and detection methods
UNIV OTTAWA33 citations96
US5919912AJul 6, 1999
Mammalian IAP antibodies and diagnostic kits
UNIV OTTAWA50 citations96
US6673917B1Jan 6, 2004
Antisense IAP nucleic acids and uses thereof
UNIV OTTAWA32 citations90
US6159948ADec 12, 2000
Therapeutic and drug screening methods for the treatment and prevention of neuronal disease
UNIV OTTAWA26 citations89
US6020127AFeb 1, 2000
Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy
UNIV OTTAWA32 citations88
US6994957B2Feb 7, 2006
Use of neuronal apoptosis inhibitor protein (NAIP)
UNIV OTTAWA1 citations62
US6977158B1Dec 20, 2005
Mammalian IAP gene family, primers, probes, and detection methods
UNIV OTTAWA2 citations62
US6331412B1Dec 18, 2001
Methods and compounds for modulating male fertility
UNIV OTTAWA1 citations53
US7776552B2Aug 17, 2010
Mammalian IAP gene family, primers, probes and detection methods
UNIV OTTAWA0 citations52
US7235372B2Jun 26, 2007
Use of neuronal apoptosis inhibitor protein (NAIP)
UNIV OTTAWA0 citations48
US6429011B1Aug 6, 2002
Neuronal apoptosis inhibitor protein gene sequence and mutations causative of spinal muscular atrophy
UNIV OTTAWA0 citations48
US6797473B2Sep 28, 2004
Methods and compounds for modulating male fertility
UNIV OTTAWA0 citations42
AEGERA THERAPEUTICS INC
10 patentsUS6300492B1Oct 9, 2001
Modulation of IAPs for the diagnosis and antisense treatment of proliferative disease
AEGERA THERAPEUTICS INC33 citations95
US6656704B1Dec 2, 2003
Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
AEGERA THERAPEUTICS INC24 citations92
US6541457B2Apr 1, 2003
Mammalian IAP gene family, primers, probes and detection methods
AEGERA THERAPEUTICS INC16 citations92
US7087584B2Aug 8, 2006
Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
AEGERA THERAPEUTICS INC12 citations91
US6709866B2Mar 23, 2004
Methods for enhancing survival of a neuron
AEGERA THERAPEUTICS INC16 citations89
US6946544B2Sep 20, 2005
XAF genes and polypeptides: methods and reagents for modulating apoptosis
AEGERA THERAPEUTICS INC8 citations73
US6689562B1Feb 10, 2004
Mammalian IAP gene family, primers, probes and detection methods
AEGERA THERAPEUTICS INC4 citations73
US7294713B2Nov 13, 2007
Antisense IAP oligonucleotides and uses thereof
AEGERA THERAPEUTICS INC9 citations71
US6495339B1Dec 17, 2002
Method of identifying a compound that modulates XAF-mediated apoptosis
AEGERA THERAPEUTICS INC3 citations62
US7067281B2Jun 27, 2006
Mammalian IAP gene family, primers, probes and detection methods
AEGERA THERAPEUTICS INC0 citations52
APOPTOGEN INC
5 patentsUS6133437AOct 17, 2000
Modulation of IAPs for the treatment of proliferative diseases
APOPTOGEN INC68 citations94
US6107041AAug 22, 2000
Detection and modulation of IAPS for the diagnosis and treatment of proliferative disease
APOPTOGEN INC41 citations94
US6107088AAug 22, 2000
XAF genes and polypeptides: methods and reagents for modulating apoptosis
APOPTOGEN INC19 citations92
US6171821B1Jan 9, 2001
XIAP IRES and uses thereof
APOPTOGEN INC43 citations91
US6159709ADec 12, 2000
XIAP IRES and uses thereof
APOPTOGEN INC28 citations91